Contact information
John Geddes
MD FRCPsych
WA Handley Professor of Psychiatry
Mood Disorders, Bipolar Disorder, Clinical Trials
John has led several trials and research syntheses which have had major influence on clinical practice internationally.
John is a member of the Academia Europaea, an Honorary Fellow of the American College of Psychiatrists and was awarded the European College of Neuropsychopharmacology (ECNP) Neuropsychopharmacology Award in 2016 in recognition of his ground-breaking work on the psychopharmacology of bipolar disorder. He was awarded an honorary doctorate by Aristotle University of Thessaloniki in 2018.
His current research focuses on the development and evaluation of treatments for people with mood disorders. John has developed new approaches to self management and monitoring, and conducted key clinical trials as well as influential research syntheses.
Recent publications
-
Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.
Journal article
Sen A. et al, (2024), Epilepsia Open
-
Artificial intelligence and cybercrime: implications for individuals and the healthcare sector.
Journal article
Monteith S. et al, (2024), Br J Psychiatry, 1 - 3
-
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
Journal article
Taquet M. et al, (2024), Lancet Psychiatry
-
Implications of Online Self-Diagnosis in Psychiatry.
Journal article
Monteith S. et al, (2024), Pharmacopsychiatry, 57, 45 - 52
-
Co-design of 'Ways of Being', a web-based experience to optimise online arts and culture for mental health in young people.
Journal article
Syed Sheriff RJ. et al, (2024), BJPsych Bull, 1 - 8